Cyclosporine A alters expression of renal microRNAs: New insights into calcineurin inhibitor nephrotoxicity.

Calcineurin inhibitors are powerful immunosuppressants that revolutionized organ transplantation. However, non-immune effects of the calcineurin inhibitor, such as cyclosporine A (CsA), have significantly hindered their use. Specifically, nephrotoxicity, which is associated with tubulointerstitial f...

Full description

Bibliographic Details
Main Authors: Jennifer L Gooch, Clayton King, Cynthia E Francis, Paul S Garcia, Yun Bai
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5393575?pdf=render
_version_ 1818081969622220800
author Jennifer L Gooch
Clayton King
Cynthia E Francis
Paul S Garcia
Yun Bai
author_facet Jennifer L Gooch
Clayton King
Cynthia E Francis
Paul S Garcia
Yun Bai
author_sort Jennifer L Gooch
collection DOAJ
description Calcineurin inhibitors are powerful immunosuppressants that revolutionized organ transplantation. However, non-immune effects of the calcineurin inhibitor, such as cyclosporine A (CsA), have significantly hindered their use. Specifically, nephrotoxicity, which is associated with tubulointerstitial fibrosis, inflammation, and podocyte damage, affects up to half of all transplant patients. Calcineurin is involved in many aspects of kidney development and function; therefore, mechanisms of CsA-induced nephrotoxicity are complex and not yet fully understood. MicroRNAs are short non-coding RNAs that regulate protein-coding RNA expression through post-translational repression of target messenger RNAs. MicroRNA dysregulation is known to be involved in kidney diseases including fibrosis. In this study, we compared the renal microRNA expression profiles between mice that received CsA (20 mg/kg) or vehicle daily for six weeks. The results demonstrate that CsA induces significant changes in renal microRNA expression profile. We used combined criteria of False Discovery Rate (≤0.1), fold change (≥2) and median signal strength (≥50) and identified 76 differencially expressed microRNAs. This approach identified microRNAs previously linked to renal fibrosis that includes let-7d, miR-21, miR-29, miR-30, miR-130, miR-192, and miR-200 as well as microRNAs that have not been reported to be related to nephrotoxicity or immunosuppression. Pathway analysis of microRNA/mRNA changes highlights the Wnt, TGF-β, mTOR, and VEGF pathways. The mRNA expression profiles were compared in the same samples. The change of mRNA and microRNA profiles showed close correlations. To validate that the observed microRNA and mRNA expression level changes in mice kidney tissue were directly related to CsA treatment, the expression change induced by CsA treatment of three microRNAs (miR-21, miR-186, and miR-709) and three mRNAs (BMPR1a, SMURF1 and SMAD7) were compared in HEK293 cell line. A similar trend of expression level change was induced by CsA treatment in all selected microRNAs and mRNAs in the in vitro cell model. These data provide a roadmap for future work to study the role of the known and novel candidate microRNAs in the mechanism of nephrotoxicity and their further therapeutic potential.
first_indexed 2024-12-10T19:14:39Z
format Article
id doaj.art-c147e34fcbcb432f8dc6efd319a6d8be
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-10T19:14:39Z
publishDate 2017-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-c147e34fcbcb432f8dc6efd319a6d8be2022-12-22T01:36:38ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01124e017524210.1371/journal.pone.0175242Cyclosporine A alters expression of renal microRNAs: New insights into calcineurin inhibitor nephrotoxicity.Jennifer L GoochClayton KingCynthia E FrancisPaul S GarciaYun BaiCalcineurin inhibitors are powerful immunosuppressants that revolutionized organ transplantation. However, non-immune effects of the calcineurin inhibitor, such as cyclosporine A (CsA), have significantly hindered their use. Specifically, nephrotoxicity, which is associated with tubulointerstitial fibrosis, inflammation, and podocyte damage, affects up to half of all transplant patients. Calcineurin is involved in many aspects of kidney development and function; therefore, mechanisms of CsA-induced nephrotoxicity are complex and not yet fully understood. MicroRNAs are short non-coding RNAs that regulate protein-coding RNA expression through post-translational repression of target messenger RNAs. MicroRNA dysregulation is known to be involved in kidney diseases including fibrosis. In this study, we compared the renal microRNA expression profiles between mice that received CsA (20 mg/kg) or vehicle daily for six weeks. The results demonstrate that CsA induces significant changes in renal microRNA expression profile. We used combined criteria of False Discovery Rate (≤0.1), fold change (≥2) and median signal strength (≥50) and identified 76 differencially expressed microRNAs. This approach identified microRNAs previously linked to renal fibrosis that includes let-7d, miR-21, miR-29, miR-30, miR-130, miR-192, and miR-200 as well as microRNAs that have not been reported to be related to nephrotoxicity or immunosuppression. Pathway analysis of microRNA/mRNA changes highlights the Wnt, TGF-β, mTOR, and VEGF pathways. The mRNA expression profiles were compared in the same samples. The change of mRNA and microRNA profiles showed close correlations. To validate that the observed microRNA and mRNA expression level changes in mice kidney tissue were directly related to CsA treatment, the expression change induced by CsA treatment of three microRNAs (miR-21, miR-186, and miR-709) and three mRNAs (BMPR1a, SMURF1 and SMAD7) were compared in HEK293 cell line. A similar trend of expression level change was induced by CsA treatment in all selected microRNAs and mRNAs in the in vitro cell model. These data provide a roadmap for future work to study the role of the known and novel candidate microRNAs in the mechanism of nephrotoxicity and their further therapeutic potential.http://europepmc.org/articles/PMC5393575?pdf=render
spellingShingle Jennifer L Gooch
Clayton King
Cynthia E Francis
Paul S Garcia
Yun Bai
Cyclosporine A alters expression of renal microRNAs: New insights into calcineurin inhibitor nephrotoxicity.
PLoS ONE
title Cyclosporine A alters expression of renal microRNAs: New insights into calcineurin inhibitor nephrotoxicity.
title_full Cyclosporine A alters expression of renal microRNAs: New insights into calcineurin inhibitor nephrotoxicity.
title_fullStr Cyclosporine A alters expression of renal microRNAs: New insights into calcineurin inhibitor nephrotoxicity.
title_full_unstemmed Cyclosporine A alters expression of renal microRNAs: New insights into calcineurin inhibitor nephrotoxicity.
title_short Cyclosporine A alters expression of renal microRNAs: New insights into calcineurin inhibitor nephrotoxicity.
title_sort cyclosporine a alters expression of renal micrornas new insights into calcineurin inhibitor nephrotoxicity
url http://europepmc.org/articles/PMC5393575?pdf=render
work_keys_str_mv AT jenniferlgooch cyclosporineaaltersexpressionofrenalmicrornasnewinsightsintocalcineurininhibitornephrotoxicity
AT claytonking cyclosporineaaltersexpressionofrenalmicrornasnewinsightsintocalcineurininhibitornephrotoxicity
AT cynthiaefrancis cyclosporineaaltersexpressionofrenalmicrornasnewinsightsintocalcineurininhibitornephrotoxicity
AT paulsgarcia cyclosporineaaltersexpressionofrenalmicrornasnewinsightsintocalcineurininhibitornephrotoxicity
AT yunbai cyclosporineaaltersexpressionofrenalmicrornasnewinsightsintocalcineurininhibitornephrotoxicity